159
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Three Novel Sequence Types Carbapenem-Resistant Klebsiella pneumoniae Strains ST5365, ST5587, ST5647 Isolated from Two Tertiary Teaching General Hospitals in Shanxi Province, in North China: Molecular Characteristics, Resistance and Virulence Factors

, , , , , , & ORCID Icon show all
Pages 2551-2563 | Published online: 18 May 2022

References

  • Martin RM, Bachman MA. Colonization, infection, and the accessory genome of Klebsiella pneumoniae. Front Cell Infect Microbiol. 2018;8:4. doi:10.3389/fcimb.2018.00004
  • Hu Y, Liu C, Shen Z, et al. Prevalence, risk factors and molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae in patients from Zhejiang, China, 2008–2018. Emerg Microbes Infect. 2020;9(1):1771–1779. doi:10.1080/22221751.2020.1799721
  • Hu F, Guo Y, Yang Y, et al. Resistance reported from China antimicrobial surveillance network (CHINET) in 2018. Eur J Clin Microbiol Infect Dis. 2019;38(12):2275–2281. doi:10.1007/s10096-019-03673-1
  • Lin D, Chen J, Yang Y, Cheng J, Sun C. Epidemiological Study of Carbapenem-resistant Klebsiella pneumoniae. Open Med. 2018;13:460–466. doi:10.1515/med-2018-0070
  • Zhao Y, Liao Y, Zhang N, et al. Four types of ST11 novel mutations from increasing Carbapenem-Resistant Klebsiella pneumoniae in Guangdong, 2016–2020. Front Microbiol. 2021;12:702941. doi:10.3389/fmicb.2021.702941
  • Zhang X, Li F, Cui S, et al. Prevalence and distribution characteristics of blaKPC-2 and blaNDM-1 genes in Klebsiella pneumoniae. Infect Drug Resist. 2020;13:2901–2910. doi:10.2147/IDR.S253631
  • Kong Y, Sun Q, Chen H, et al. Transmission dynamics of Carbapenem-Resistant Klebsiella pneumoniae sequence type 11 strains carrying capsular loci KL64 and rmpA/rmpA2 genes. Front Microbiol. 2021;12:736896. doi:10.3389/fmicb.2021.736896
  • Wang G, Zhao G, Chao X, Xie L, Wang H. The characteristic of virulence, biofilm and antibiotic resistance of Klebsiella pneumoniae. Int J Environ Res Public Health. 2020;17(17):6278. doi:10.3390/ijerph17176278
  • Ballen V, Gabasa Y, Ratia C, Ortega R, Tejero M, Soto S. Antibiotic resistance and virulence profiles of Klebsiella pneumoniae strains isolated from different clinical sources. Front Cell Infect Microbiol. 2021;11:738223. doi:10.3389/fcimb.2021.738223
  • Liu L, Feng Y, Long H, McNally A, Zong Z. Sequence Type 273 Carbapenem-Resistant Klebsiella pneumoniae carrying bla NDM-1 and bla IMP-4. Antimicrob Agents Chemother. 2018;62(6). doi:10.1128/AAC.00160-18
  • Qi Y, Wei Z, Ji S, Du X, Shen P, Yu Y. ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China. J Antimicrob Chemother. 2011;66(2):307–312. doi:10.1093/jac/dkq431
  • Choby JE, Howard Anderson J, Weiss DS. Hypervirulent Klebsiella pneumoniae – clinical and molecular perspectives. J Intern Med. 2020;287(3):283–300. doi:10.1111/joim.13007
  • Gato E, Vazquez-Ucha JC, Rumbo-Feal S, et al. Kpi, a chaperone-usher pili system associated with the worldwide-disseminated high-risk clone Klebsiella pneumoniae ST-15. Proc Natl Acad Sci U S A. 2020;117(29):17249–17259. doi:10.1073/pnas.1921393117
  • Zou H, Shen Y, Li C, Li Q. Two phenotypes of Klebsiella pneumoniae ST147 outbreak from neonatal sepsis with a slight increase in virulence. Infect Drug Resist. 2022;15:1–12. doi:10.2147/IDR.S343292
  • David S, Reuter S, Harris SR, et al. Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread. Nat Microbiol. 2019;4(11):1919–1929. doi:10.1038/s41564-019-0492-8
  • Lan P, Jiang Y, Zhou J, Yu Y. A global perspective on the convergence of hypervirulence and carbapenem resistance in Klebsiella pneumoniae. J Glob Antimicrob Resist. 2021;25:26–34. doi:10.1016/j.jgar.2021.02.020
  • Lu B, Lin C, Liu H, et al. Molecular characteristics of Klebsiella pneumoniae isolates from outpatients in Sentinel Hospitals, Beijing, China, 2010–2019. Front Cell Infect Microbiol. 2020;10:85. doi:10.3389/fcimb.2020.00085
  • Zhou C, Wu Q, He L, et al. Clinical and molecular characteristics of Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae isolates in a Tertiary Hospital in Shanghai, China. Infect Drug Resist. 2021;14:2697–2706. doi:10.2147/IDR.S321704
  • Zhang S, Zhang X, Wu Q, et al. Clinical, microbiological, and molecular epidemiological characteristics of Klebsiella pneumoniae-induced pyogenic liver abscess in southeastern China. Antimicrob Resist Infect Control. 2019;8(1):166. doi:10.1186/s13756-019-0615-2
  • Zhou K, Xiao T, David S, et al. Novel subclone of Carbapenem-Resistant Klebsiella pneumoniae sequence type 11 with enhanced virulence and transmissibility, China. Emerg Infect Dis. 2020;26(2):289–297. doi:10.3201/eid2602.190594
  • Zhao D, Shi Q, Hu D, et al. The emergence of novel sequence type strains reveals an evolutionary process of intraspecies clone shifting in ICU-spreading Carbapenem-Resistant Klebsiella pneumoniae. Front Microbiol. 2021;12:691406. doi:10.3389/fmicb.2021.691406
  • Wang X, Li Q, Kang J, et al. Co-production of NDM-1, CTX-M-9 family and mcr-1 in a Klebsiella pneumoniae ST4564 Strain in China. Infect Drug Resist. 2021;14:449–457. doi:10.2147/IDR.S292820
  • Wang Q, Wang X, Wang J, et al. Phenotypic and genotypic characterization of Carbapenem-Resistant Enterobacteriaceae: data from a Longitudinal Large-scale CRE Study in China (2012–2016). Clin Infect Dis. 2018;67(suppl_2):S196–S205. doi:10.1093/cid/ciy660
  • Chen CM, Wang M, Li XP, et al. Homology analysis between clinically isolated extraintestinal and enteral Klebsiella pneumoniae among neonates. BMC Microbiol. 2021;21(1):25. doi:10.1186/s12866-020-02073-2
  • Jin C, Shi R, Jiang X, Zhou F, Qiang J, An C. Epidemic characteristics of Carbapenem-Resistant Klebsiella pneumoniae in the pediatric intensive care unit of Yanbian University Hospital, China. Infect Drug Resist. 2020;13:1439–1446. doi:10.2147/IDR.S245397
  • Li Z, Ding Z, Yang J, et al. Carbapenem-Resistant Klebsiella pneumoniae in Southwest China: molecular characteristics and risk factors caused by KPC and NDM producers. Infect Drug Resist. 2021;14:3145–3158. doi:10.2147/IDR.S324244
  • Wang TC, Lin JC, Chang JC, et al. Virulence among different types of hypervirulent Klebsiella pneumoniae with multi-locus sequence type (MLST)-11, Serotype K1 or K2 strains. Gut Pathog. 2021;13(1):40. doi:10.1186/s13099-021-00439-z
  • Walker KA, Miller VL. The intersection of capsule gene expression, hypermucoviscosity and hypervirulence in Klebsiella pneumoniae. Curr Opin Microbiol. 2020;54:95–102. doi:10.1016/j.mib.2020.01.006
  • Zhu J, Wang T, Chen L, Du H. Virulence Factors in Hypervirulent Klebsiella pneumoniae. Front Microbiol. 2021;12:642484. doi:10.3389/fmicb.2021.642484
  • Chen L, Yu K, Chen L, et al. Synergistic activity and biofilm formation effect of colistin combined with PFK-158 against colistin-resistant gram-negative bacteria. Infect Drug Resist. 2021;14:2143–2154. doi:10.2147/IDR.S309912
  • Andrade NL, Da CCAC, Cabral AM, et al. Infective endocarditis caused by Enterobacteriaceae: phenotypic and molecular characterization of Escherichia coli and Klebsiella pneumoniae in Rio de Janeiro, Brazil. Braz J Microbiol. 2021;52(4):1887–1896. doi:10.1007/s42770-021-00528-w
  • Podschun R, Sievers D, Fischer A, Ullmann U. Serotypes, hemagglutinins, siderophore synthesis, and serum resistance of Klebsiella isolates causing human urinary tract infections. J Infect Dis. 1993;168(6):1415–1421. doi:10.1093/infdis/168.6.1415
  • Wang M, Earley M, Chen L, et al. Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study. Lancet Infect Dis. 2022;22(3):401–412. doi:10.1016/S1473-3099(21)00399-6
  • Zhen X, Stålsby LC, Sun X, Gu S, Dong H. Clinical and economic burden of Carbapenem-Resistant infection or colonization caused by Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii: a Multicenter Study in China. Antibiotics. 2020;9(8). doi:10.3390/antibiotics9080514
  • Gao H, Liu Y, Wang R, Wang Q, Jin L, Wang H. The transferability and evolution of NDM-1 and KPC-2 co-producing Klebsiella pneumoniae from clinical settings. EBioMedicine. 2020;51:102599. doi:10.1016/j.ebiom.2019.102599
  • Rasmussen BA, Bush K, Keeney D, et al. Characterization of IMI-1 beta-lactamase, a class A carbapenem-hydrolyzing enzyme from Enterobacter cloacae. Antimicrob Agents Chemother. 1996;40(9):2080–2086. doi:10.1128/AAC.40.9.2080
  • Evans BA, Amyes SG. OXA β-lactamases. Clin Microbiol Rev. 2014;27(2):241–263. doi:10.1128/CMR.00117-13
  • Zhu J, Li Q, Li X, et al. Successful control of the first carbapenem-resistant Klebsiella pneumoniae outbreak in a Chinese hospital 2017–2019. Antimicrob Resist Infect Control. 2020;9(1):91. doi:10.1186/s13756-020-00757-y
  • Wu X, Shi Q, Shen S, Huang C, Wu H. Clinical and bacterial characteristics of Klebsiella pneumoniae affecting 30-day mortality in patients with bloodstream infection. Front Cell Infect Microbiol. 2021;11:688989. doi:10.3389/fcimb.2021.688989
  • Fang CT, Chuang YP, Shun CT, Chang SC, Wang JT. A novel virulence gene in Klebsiella pneumoniae strains causing primary liver abscess and septic metastatic complications. J Exp Med. 2004;199(5):697–705. doi:10.1084/jem.20030857
  • Su S, Zhang J, Zhao Y, et al. Outbreak of KPC-2 Carbapenem-Resistant Klebsiella pneumoniae ST76 and Carbapenem-Resistant K2 Hypervirulent Klebsiella pneumoniae ST375 strains in Northeast China: molecular and virulent characteristics. BMC Infect Dis. 2020;20(1):472. doi:10.1186/s12879-020-05143-y
  • Tomas JM, Benedi VJ, Ciurana B, Jofre J. Role of capsule and O antigen in resistance of Klebsiella pneumoniae to serum bactericidal activity. Infect Immun. 1986;54(1):85–89. doi:10.1128/iai.54.1.85-89.1986
  • Paczosa MK, Mecsas J. Klebsiella pneumoniae: going on the offense with a strong defense. Microbiol Mol Biol Rev. 2016;80(3):629–661. doi:10.1128/MMBR.00078-15
  • Liao W, Liu Y, Zhang W. Virulence evolution, molecular mechanisms of resistance and prevalence of ST11 carbapenem-resistant Klebsiella pneumoniae in China: a review over the last 10 years. J Glob Antimicrob Resist. 2020;23:174–180. doi:10.1016/j.jgar.2020.09.004